BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 30610106)

  • 1. Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases:
    Gordhandas S; Da Cruz Paula A; Kertowidjojo EC; Pareja F; Dessources K; da Silva EM; Derakhshan F; Mueller JJ; Abu-Rustum NR; Herman Chui M; Weigelt B
    Gynecol Oncol Rep; 2024 Jun; 53():101391. PubMed ID: 38633674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatially resolved multiomics of human cardiac niches.
    Kanemaru K; Cranley J; Muraro D; Miranda AMA; Ho SY; Wilbrey-Clark A; Patrick Pett J; Polanski K; Richardson L; Litvinukova M; Kumasaka N; Qin Y; Jablonska Z; Semprich CI; Mach L; Dabrowska M; Richoz N; Bolt L; Mamanova L; Kapuge R; Barnett SN; Perera S; Talavera-López C; Mulas I; Mahbubani KT; Tuck L; Wang L; Huang MM; Prete M; Pritchard S; Dark J; Saeb-Parsy K; Patel M; Clatworthy MR; Hübner N; Chowdhury RA; Noseda M; Teichmann SA
    Nature; 2023 Jul; 619(7971):801-810. PubMed ID: 37438528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author Correction: Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro.
    Garcia-Alonso L; Handfield LF; Roberts K; Nikolakopoulou K; Fernando RC; Gardner L; Woodhams B; Arutyunyan A; Polanski K; Hoo R; Sancho-Serra C; Li T; Kwakwa K; Tuck E; Lorenzi V; Massalha H; Prete M; Kleshchevnikov V; Tarkowska A; Porter T; Mazzeo CI; van Dongen S; Dabrowska M; Vaskivskyi V; Mahbubani KT; Park JE; Jimenez-Linan M; Campos L; Kiselev VY; Lindskog C; Ayuk P; Prigmore E; Stratton MR; Saeb-Parsy K; Moffett A; Moore L; Bayraktar OA; Teichmann SA; Turco MY; Vento-Tormo R
    Nat Genet; 2023 Jan; 55(1):165. PubMed ID: 36539619
    [No Abstract]   [Full Text] [Related]  

  • 4. Using advanced spatial and single-cell transcriptomics to characterize the human endometrium.
    Wang X; Hawkins SM
    Nat Genet; 2021 Dec; 53(12):1628-1630. PubMed ID: 34857955
    [No Abstract]   [Full Text] [Related]  

  • 5. Mapping the temporal and spatial dynamics of the human endometrium in vivo and in vitro.
    Garcia-Alonso L; Handfield LF; Roberts K; Nikolakopoulou K; Fernando RC; Gardner L; Woodhams B; Arutyunyan A; Polanski K; Hoo R; Sancho-Serra C; Li T; Kwakwa K; Tuck E; Lorenzi V; Massalha H; Prete M; Kleshchevnikov V; Tarkowska A; Porter T; Mazzeo CI; van Dongen S; Dabrowska M; Vaskivskyi V; Mahbubani KT; Park JE; Jimenez-Linan M; Campos L; Kiselev VY; Lindskog C; Ayuk P; Prigmore E; Stratton MR; Saeb-Parsy K; Moffett A; Moore L; Bayraktar OA; Teichmann SA; Turco MY; Vento-Tormo R
    Nat Genet; 2021 Dec; 53(12):1698-1711. PubMed ID: 34857954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids.
    Haider S; Gamperl M; Burkard TR; Kunihs V; Kaindl U; Junttila S; Fiala C; Schmidt K; Mendjan S; Knöfler M; Latos PA
    Endocrinology; 2019 Oct; 160(10):2282-2297. PubMed ID: 31290979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).
    Li Y; Zhu C; Xie H; Chen Y; Lv W; Xie X; Wang X
    J Gynecol Oncol; 2023 Mar; 34(2):e37. PubMed ID: 36659832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
    Bonazzi VF; Kondrashova O; Smith D; Nones K; Sengal AT; Ju R; Packer LM; Koufariotis LT; Kazakoff SH; Davidson AL; Ramarao-Milne P; Lakis V; Newell F; Rogers R; Davies C; Nicklin J; Garrett A; Chetty N; Perrin L; Pearson JV; Patch AM; Waddell N; Pollock PM
    Genome Med; 2022 Jan; 14(1):3. PubMed ID: 35012638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors.
    Harms PW; Verhaegen ME; Hu K; Hrycaj SM; Chan MP; Liu CJ; Grachtchouk M; Patel RM; Udager AM; Dlugosz AA
    Mod Pathol; 2022 Apr; 35(4):506-514. PubMed ID: 34593967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.
    Plaska SW; Liu CJ; Lim JS; Rege J; Bick NR; Lerario AM; Hammer GD; Giordano TJ; Else T; Tomlins SA; Rainey WE; Udager AM
    Horm Metab Res; 2020 Aug; 52(8):607-613. PubMed ID: 32791542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes.
    Lazo de la Vega L; Bick N; Hu K; Rahrig SE; Silva CD; Matayoshi S; Picciarelli P; Wang X; Sugar A; Soong HK; Mian SI; Robinson DR; Chinnaiyan AM; Demirci H; Daniels AB; Worden F; Eberhart CG; Tomlins SA; Rao RC; Harms PW
    Mod Pathol; 2020 Nov; 33(11):2280-2294. PubMed ID: 32461624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic Medical Record Search Engine (EMERSE): An Information Retrieval Tool for Supporting Cancer Research.
    Hanauer DA; Barnholtz-Sloan JS; Beno MF; Del Fiol G; Durbin EB; Gologorskaya O; Harris D; Harnett B; Kawamoto K; May B; Meeks E; Pfaff E; Weiss J; Zheng K
    JCO Clin Cancer Inform; 2020 May; 4():454-463. PubMed ID: 32412846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving response to progestin treatment of low-grade endometrial cancer.
    Baxter E; Brennan DJ; McAlpine JN; Mueller JJ; Amant F; van Gent MDJM; Huntsman DG; Coleman RL; Westin SN; Yates MS; Krakstad C; Quinn MA; Janda M; Obermair A
    Int J Gynecol Cancer; 2020 Nov; 30(11):1811-1823. PubMed ID: 32381512
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Faisal FA; Murali S; Kaur H; Vidotto T; Guedes LB; Salles DC; Kothari V; Tosoian JJ; Han S; Hovelson DH; Hu K; Spratt DE; Baras AS; Tomlins SA; Schaeffer EM; Lotan TL
    Clin Cancer Res; 2020 Jun; 26(11):2595-2602. PubMed ID: 31969336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical actionability of molecular targets in endometrial cancer.
    Urick ME; Bell DW
    Nat Rev Cancer; 2019 Sep; 19(9):510-521. PubMed ID: 31388127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma.
    Lazo de la Vega L; Samaha MC; Hu K; Bick NR; Siddiqui J; Hovelson DH; Liu CJ; Carter CS; Cho KR; Sciallis AP; Tomlins SA
    Mol Cancer Res; 2019 Mar; 17(3):731-740. PubMed ID: 30610106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
    Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
    Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer.
    Malentacchi F; Turrini I; Sorbi F; Projetto E; Castiglione F; Fambrini M; Petraglia F; Pillozzi S; Noci I
    Oncol Rep; 2019 Mar; 41(3):1560-1574. PubMed ID: 30569174
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.